Products
Investing
Resources
Support
Gland Pharma Limited (GLAND)
₹1,400
INR-78.70(-5.32%)
As of April 30, 2025 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹23564.72 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹21369.12 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
33.09
Forward P/E
Price to Earnings ratio based on forecasted earnings
21.74
PEG Ratio
Price/Earnings to Growth ratio
21.74
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
4.11
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
66.57%
Operating Margin
Operating income as a percentage of revenue
19.05%
Return on Equity
Net income as a percentage of shareholders' equity
8.85%
Revenue (TTM)
Total revenue over trailing 12 months
₹5729.04 Cr-10.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1494.36 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹42.71+6.7%
Balance Sheet
Total Cash
Total cash and short-term investments
₹2820.11 Cr
Total Debt
Total short-term and long-term debt
₹326.63 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
3.72%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1277.8 - ₹2220.95
Beta
Measure of stock's volatility compared to the market
0.29
Shares Outstanding
Total number of shares issued by the company
₹16.47 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.38%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
46.77%